Related Experiment Videos
Gamma irradiation of HIV-1
R A Smith1, J Ingels, J J Lochemes
1Department of Orthopaedic Surgery, University of Tennessee-Campbell Clinic, Memphis 38163, USA. rsmith@utmem.edu
Summary
Gamma irradiation up to 5.0 Mrad did not inactivate human immunodeficiency virus (HIV) type 1 in vitro. Current screening methods are more reliable for ensuring allograft safety than gamma sterilization against HIV transmission.
Area of Science:
- Virology
- Biomedical Engineering
- Infectious Diseases
Background:
- Human immunodeficiency virus (HIV) transmission risk associated with allografts is a significant clinical concern.
- Standard gamma irradiation doses (1.5-2.5 Mrad) for tissue sterilization may compromise allograft quality.
- The efficacy of gamma irradiation in inactivating HIV type 1 requires further investigation.
Purpose of the Study:
- To determine the effectiveness of gamma irradiation in inactivating HIV type 1.
- To assess the impact of increasing irradiation doses on HIV type 1 infectivity and replication.
Main Methods:
- In vitro inactivation of HIV type 1 using gamma irradiation at varying doses.
- Assessment of viral infectivity by T-lymphocyte and cell line cultures.
- Detection of viral replication markers: reverse transcriptase activity, p24 antigen (ELISA, immunofluorescence), and syncytia formation.
Main Results:
- Active HIV type 1 replication was observed in cell cultures exposed to irradiation doses up to 5.0 Mrad.
- Data for the 10 Mrad sample were inconclusive due to significant cellular damage.
- Standard gamma irradiation doses (1.5-2.5 Mrad) were insufficient to achieve complete viral inactivation.
Conclusions:
- Gamma irradiation at clinically relevant doses (1.5-2.5 Mrad) is not a virucidal treatment for HIV type 1.
- Surgeons should prioritize tissue bank screening and alternative preparation methods over gamma sterilization for allograft safety.
- Enhanced screening protocols are crucial for preventing HIV transmission via allografts.